Panbela Therapeutics, Inc. Profile Avatar - Palmy Investing

Panbela Therapeutics, Inc.

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pa…

Biotechnology
US, Waconia [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Panbela Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Panbela Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Panbela Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of PBLA's Analysis
CIK: 1029125 CUSIP: 69833W107 ISIN: US69833W4042 LEI: - UEI: -
Secondary Listings
PBLA has no secondary listings inside our databases.